Breadcrumb
A Blog by AMCP CEO Susan A. Cantrell, MHL, RPh, CAE
Biosimilars Will Foster Competition and Lower Costs
6/1/18
The White House made news last month with its blueprint to lower drug prices. But it's also important to note that biosimilars will play a crucial role in fostering competition and lowering costs. Biosimilars are the topic of my latest op-ed, "How to Foster Competition While Cutting Drug Costs," published last month in Morning Consult.